Evofem Biosciences Inc
EVFM·Stocks·Biotechnology·United States·OTC Markets Stock Exchange·USD
Price
$0.01
Today
-3.9%
YTD
+45.3%
About
Evofem develops and commercialises products to address women's sexual and reproductive health needs. Founded in 2009, the firm has created Phexxi, a vaginal gel that aids in the prevention of pregnancy. The firm has headquarters in San Diego, California and operates in the US. Evofem is listed on the NASDAQ CM stock market with the ticker EVFM. Update your eToro watchlist to track EVFM share price changes.
Price chart
Closing price history for EVFM (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.17
P/S (TTM)0.06
P/B (TTM)-0.01
Market cap$1.13M
Cap tierMicro-cap
Industry avg P/E-6.10
Profitability
Gross margin75.20%
EBIT margin-17.08%
Net margin-607.90%
ROE-387.27%
ROA-59.35%
Earnings & Revenue
Revenue (TTM)$20.24M
Revenue growth (1Y)+21.9%
EPS (TTM)-$0.05
Free cash flow-$258,000.00
Total debt$52.46M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.06
Employees29
Next earnings31 Mar '23
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.